Glycostem to present virtually on the 3^rdAllogeneic Cell Therapies Summit on 19^th May 2021, to share our experiences on comparability testing for US required raw material sourcing vs. European sourcing. 

Glycostem will present on the virtual Berenberg Conference USA 2021 on 18^th May, 2021, to share the latest updates of our company and products, and host one-on-one meetings with investors.

Glycostem to present at the 18th CIMT Annual Meeting virtually with etalk presentation: Ex vivo expanded NK cells show potent anti-tumour activity against melanoma.

Glycostem to present at virtual event Stability V: Challenges of in-use stability demonstration hosted by Joint Pharmaceutical Analysis Group, to talk about in use stability considerations for large molecules.  

Glycostem to participate the Oppenheimer 31st Annual Healthcare Conference, a virtual investor event, on Wednesday, March 17, 2021. Our CEO Troels Jordansen will provide an overview of the company and progress. Glycostem will host one-on-one meetings with investors during the event.

Glycostem will present on the virtual 10th Annual Global Healthcare Conference hosted by SVB Leerink on 23^rd Feb, 2021, to share the latest updates of our company and products, and host one-on-one meetings with investors.